Litcius/Paper detail

Hypoglycemia in diabetes: An update on pathophysiology, treatment, and prevention

Afif Nakhleh, Naim Shehadeh

2021World Journal of Diabetes146 citationsDOIOpen Access PDF

Abstract

Hypoglycemia is a common complication in patients with diabetes, mainly in those treated with insulin, sulfonylurea, or glinide. Impairments in counterregulatory responses and hypoglycemia unawareness constitute the main risk factors for severe hypoglycemia. Episodes of hypoglycemia are associated with physical and psychological morbidity. The fear of hypoglycemia constitutes a barrier that impairs the patient's ability to reach good glycemic control. To prevent hypoglycemia, much effort must be invested in patient education regarding risk factors, warning signs, and treatment of hypoglycemia at an early stage, together with setting personalized goals for glycemic control. In this review, we present a comprehensive update on the treatment and prevention of hypoglycemia in type 1 and type 2 diabetic patients.

Topics & Concepts

HypoglycemiaMedicineGlycemicIntensive care medicineSulfonylureaDiabetes mellitusComplicationType 2 diabetesPediatricsInternal medicineEndocrinologyDiabetes Management and ResearchPancreatic function and diabetesDiabetes and associated disorders
Hypoglycemia in diabetes: An update on pathophysiology, treatment, and prevention | Litcius